Relationship Between AMACR Staining Density of Radical Prostatectomy Specimen and Biochemical Recurrence in Patients with Pathological Stage T2a-b
Journal Title: The Bulletin of Urooncology - Year 2020, Vol 19, Issue 1
Abstract
Objective: This study aimed to evaluate the relationship between Alpha-methylacyl-CoA racemase (AMACR) staining intensity of pathologic specimens and Prostate Spesific Antigen (PSA) recurrence of patients with an organ-limited disease who underwent radical prostatectomy for localized prostate cancer. Materials and Methods: The data of 46 patients who underwent radical retropubic prostatectomy and who had prostate-limited disease without capsule invasion in the pathological evaluation were included in the study. AMACR expression was assessed by immunohistochemical staining. Expression levels were classified as negative (score=0), weak (score=1), moderate (score=2) and strong (score=3) staining. Patients with a PSA value of ≥0.2 ng/mL at postoperative follow-up were considered to have a biochemical recurrence. Patients were divided into two groups, according to biochemical recurrence. Groups were compared in terms of AMACR staining intensities of radical prostatectomy specimens. Results: Twenty-one patients developed PSA recurrence in a mean follow-up period of 32±8 months. The remaining 25 patients were recurrence-free. The mean recurrence time was 24±5 months. According to AMACR staining scores, the biochemical recurrence rates of the patients were 33.3%, 40.7%, and 61.5% for score 1, score 2, and score 3, respectively. Although higher rates of PSA recurrence were observed in patients with more intense AMACR staining, the difference between rates was not statistically significant (p=0.38). Conclusion: PSA recurrence rate increases with increasing AMAC-CR staining intensity. Further studies are needed to obtain statistically significant results.
Authors and Affiliations
Murat Kars, Ersin Gökmen, Oktay Özman, Serkan Gönültaş, Burak Arslan
Keywords
Related Articles
- EP ID EP685424
- DOI 10.4274/uob.galenos.2019.1381
- Views 128
- Downloads 0
Acute Ischemic Stroke Following Chemotherapy for Malignant Mixed Testicular Germ Cell Tumour: Does Cisplatin Play a Role?
Among males aged between 15 and 35 years, testicular cancer is the most commonly diagnosed cancer. Testicular germ cell tumours are generally considered curable and respond dramatically to adjuvant treatment. Cisplatin-b...
Management of Patients with Urological Cancers in Turkey during the COVID-19 Pandemic: Recommendations of Uro-oncology Association
Coronavirus disease-19 (COVID-19) has been declared as a pandemic by the World Health Organization. The number of cases has increased over time in correlation with the increasing number of testing worldwide. In order to...
Intravesical Mitomycin-C with Bladder Wall Hyperthermia in Intermediate and High-risk Non-muscle Invasive Bladder Cancers: Prospective Clinical Trial with a Singletreatment Arm
Objective: Bacillus Calmette-Guérin (BCG) limited availability, cost, and allergic response in some patients limit its use, leading to the search for alternative agents. We aimed to present the outcomes of intermediate-...
Current Approach in Radiation Therapy for Prostate Cancer
Prostate cancer is one of the most common malignancies in men. Radiotherapy is one of the main treatment modalities in the treatment of prostate cancer. The reflection of technological advances in the field of radiation...
Comparison of Prostate Cancer Detection Rates of Cognitive Fusion-targeted Biopsy and Standard Transrectal Ultrasound-guided Biopsy
Objective: The aim of this study is to investigate whether there is a difference between standard prostate needle biopsies and cognitive fusion prostate biopsies (classical 12-core plus 2 cognitive lesions) for any prost...